QA: Trevena INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001429560_2021_Trevena_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0001429560, Trevena INC

  xvar xval
0 AssetsCurrent 119,044,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,253,000
3 remainder_Assets 6,442,000
4 LiabilitiesCurrent 16,564,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 7,107,000
7 CostOfGoodsAndServicesSold 182,000
8 SellingGeneralAndAdministrativeExpense 19,894,562
9 ResearchAndDevelopmentExpense 13,155,662
10 remainder_Expenses -3,383
11 remainder_Revenues 2,783,617
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 607,697
  yvar yval
0 Assets 127,739,000
1 Liabilities 23,671,000
2 Expenses 33,228,841
3 Revenues 2,783,617
4 StockholdersEquity 104,068,000
5 NetIncome -30,445,224
6 ComprehensiveNetIncome -30,141,376
7 BaseVar 94,015,078
8 EconomicCapitalRatiobeforeLimitedLiability 2.60
9 EconomicCapitalRatio 3.42

Edgar->Model Mapping

Feature Distribution

Change over Time